Recipharm's financial objectives and strategies

Recipharm’s objective is to be a world leading supplier of CDMO services based on market share:

• one of the top three suppliers in Europe within three years
• one of the top three suppliers in the world within five years

The financial objectives are:

• average annual sales growth higher than 15% over a business cycle, of which 5-10% will come from organic growth
• return on capital employed higher than 20% per year
• net debt to equity of less than 0.5

These will be achieved through:

• organic growth by leveraging Recipharm’s resources and capabilities across the CDMO market
• additional growth from selected acquisitions that support, differentiate and develop the Company’s competitive position
• highly efficient operations
• increased contribution of own technology and IP to total sales

Investor contact

Björn Westberg

T: +46 8 602 52 00